Table 3.
Characteristics and Antibiotic Resistance Profiles for SCCmec Types Among MRSA Isolates in Children with Cystic Fibrosis
| Antimicrobial agenta | Prevalence of resistance among MRSA strains | |||
|---|---|---|---|---|
| MRSA Total N = 141 (%) |
SCCmec II N=117 (%) |
SCCmec IV N=24 (%) |
p | |
| Clindamycinb (N=141) | 114 (81) | 109 (93) | 5 (21) | <0.001 |
| Erythromycin (N=141) | 137 (97) | 115 (98) | 22 (92) | 0.134 |
| Trimethoprim-Sulfamethoxazole (N=138) | 5 (4) | 5 (4) | 0 (0) | 1.00 |
| Rifampin (N=113) | 9 (8) | 9 (8) | 0 (0) | 1.00 |
| Tetracycline (N=113) | 6 (5) | 6 (6) | 0 (0) | 1.00 |
| Mupirocin (N=141) | 2 (1) | 2 (2) | 0 (0) | 1.00 |
a
No linezolid resistance detected
b
Includes inducible resistance